Who Owns CMMB?

Chemomab Therapeutics Ltd. — Institutional Ownership & 13F Holdings

$1.53

-0.01 (-0.65%)

Market Cap

$12.3M

Shares Outstanding

6,155,117

Institutional Holders

17

Total Inst. Value

$15.1M

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

3

Closed Positions

1

Increased

7

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GAMMA Investing LLC$11.0M12,021
2ORBIMED ADVISORS LLC$1.9M1,741,273
3SPHERA FUNDS MANAGEMENT LTD.$981K900,428
4Yelin Lapidot Holdings Management Ltd.$630K578,291
5Ikarian Capital, LLC$232K213,052
6MORGAN STANLEY$127K117,160
7KESTRA PRIVATE WEALTH SERVICES, LLC$34K31,241
8Virtu Financial LLC$34K30,803
9BOOTHBAY FUND MANAGEMENT, LLC$29K26,189
10RHUMBLINE ADVISERS$26K23,849

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
GAMMA Investing LLC+7K$11.0M
MORGAN STANLEY+13K$127K
Virtu Financial LLC+16K$34K
RHUMBLINE ADVISERS+41$26K
TWO SIGMA SECURITIES, LLCNew+22K$24K

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CMMB?

As of Q1 2025, 17 institutional investors report holding CMMB (Chemomab Therapeutics Ltd.) in their 13F filings.

Which hedge fund owns the most CMMB?

The largest institutional holder of CMMB is GAMMA Investing LLC with $11.0M in shares.

Are institutions buying or selling CMMB?

This quarter, 3 institutions opened new positions in CMMB and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.